News and Trends 15 Aug 2022 Short Wave Pharma to start clinical trial for anorexia nervosa treatment Short Wave Pharma Inc., a biopharma company developing patent pending psychedelic compositions and methods of delivery, has signed a clinical trial agreement with the Sheba Fund for Health Services and Research and with Eitan Gur, principal investigator and head of the Sheba Medical Center Department for Eating Disorders, and Yoel Golbert, co–investigator at the center. […] August 15, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 10 Aug 2022 Epilepsy drug accepted for review in Canada and Israel SK Biopharmaceuticals, Co., Ltd. says Health Canada has accepted Paladin Labs Inc.’s filing of a new drug submission (NDS) for cenobamate as an adjunctive therapy for the management of partial-onset seizures in adults with epilepsy who are not satisfactorily controlled with conventional therapy. If Health Canada approves the NDS, Paladin Labs would be able to […] August 10, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 4 Aug 2022 PolyPid to receive millions for commercialization of infection-fighting drug A drug to prevent surgical site infections (SSIs) in abdominal and cardiac surgeries in Europe is to be commercialized after two companies entered an exclusive licensing agreement. Israel-based PolyPid Ltd and UK-based ADVANZ PHARMA Corp. announced the agreement for lead drug candidate D-PLEX100 yesterday (August 3). Topline results Under the terms of the agreement, PolyPid will receive […] August 4, 2022 - 3 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
In Depth 3 Aug 2022 The biggest European biotech investments in July 2022 The mRNA firm Normax Biomed snagged Europe’s biggest private biotech investment in July 2022, with runners-up including AgomAb and Tropic Biosciences. Life sciences manufacturing companies saw a big windfall in Europe in July 2022 as the Cork-based Normax Biomed bagged around $301 million. The firm is establishing modular manufacturing facilities that could provide mRNA vaccines […] August 3, 2022 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 26 Jul 2022 Israeli foodtech company develops zero-waste plant protein extraction A novel, waste-free protein extraction method that completes the sustainability loop through the sustainability practice of upcycling has been created by Acre, Israel-Gavan Technologies, Ltd. The foodtech start-up supports the circular economy by positioning total plant extraction at the core of its operations. Itai Cohen, CEO and co-founder of Gavan, said: “Our new, multistep technological […] July 26, 2022 - 4 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
News and Trends 20 Jul 2022 ICL and PlantArcBio look to use RNAi to boost crop yields ICL, a global specialty minerals company, and ag-biotech company PlantArcBio, Ltd., have announced the development of a novel bio-stimulant technology platform to improve crop yields while having a minimal impact on the environment. The platform uses RNAi (RNA interference) technology to maximize a plant’s natural yield increase mechanisms, without any genetic modification, and was the […] July 20, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 8 Jul 2022 Biotech food colorant startup Phytolon seals $14.5M in funding Phytolon, a developer of fermentation-based natural food colors, has secured $14.5 million in funding, led by DSM Venturing, to further progress its technology towards commercialization. Other participation came from Cibus Fund, Ginkgo Bioworks (in-kind investment in the form of Foundry services) and The Trendlines Agrifood Fund. Participation in the series A funding also includes some […] July 8, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 27 May 2022 Animal-free milk company Imagindairy reaches $28M in funding Israeli foodtech startup Imagindairy, Ltd., developer of animal-free dairy milk proteins, has secured an additional $15M in its extended seed-round to bring the total investment so far to $28M. The alt-protein company creates animal-free milk proteins from microorganisms through precision-fermentation technology, which allows the production of a wide range of dairy analogs, from raw milk […] May 27, 2022 - 4 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 5 Jan 2022 The Top European Biotech Investments in December December 2021 ended with a bang for biotech funding in Europe and Israel, with cultured meat and cell therapy startups attracting the biggest investment rounds. Biotech companies in Europe and Israel capped off 2021 with a very strong month of fundraising. Collectively, private companies and those launching initial public offerings (IPOs) banked almost €1.6B in […] January 5, 2022 - 4 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 23 Dec 2021 Future Meat Lands €308M in Biggest-Ever Cultured Meat Investment The Israeli firm Future Meat Technologies has raised a neat €308M ($347M) in the biggest financing round in the field of cultured meat to date. The company claims rapid progress in addressing scaling bottlenecks that slow the sector’s growth. A range of contributors pitched into the mammoth funding round including an undisclosed tech investor, ADM […] December 23, 2021 - 5 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 21 Sep 2021 Europe’s Antibiotic Investments Stagnate As Resistance Crisis Looms Despite the urgent danger of antibiotic resistance, investments into European biotech antibiotic players have remained flat. However, growing regulatory and societal awareness could spell fresh investments in the coming years. Over the last decade, pressure has been mounting on healthcare systems as infectious microbes become harder and harder to fight with antibiotics. Some strains of […] September 21, 2021 - 7 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 29 Apr 2020 Pluristem Scores €50M From EIB to Develop Covid-19 Cell Therapy Israeli cell therapy biotech Pluristem Therapeutics has secured up to €50M in non-dilutive funding from the European Investment Bank to progress its coronavirus-targeting cell therapy to phase III. The partners plan to sign the funding agreement at the end of April and Pluristem will initially receive €20M followed by two further installments totaling up to […] April 29, 2020 - 3 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email